History | Ofatumumab for treating relapsing multiple sclerosis | Guidance | NICE

History

Declaration of interests

Register of interests (PDF 149 KB)

Published:

19 May 2021
Equality Impact Assessment (Guidance development) (PDF 141 KB)

Published:

19 May 2021

Final draft guidance

Final appraisal document (MSWord 56 KB)

Published:

20 April 2021
Committee papers (PDF 3.92 MB)

Published:

20 April 2021

Invitation to participate

Equality Impact Assessment (Guidance development) (PDF 120 KB)

Published:

02 June 2020
Final scope (PDF 209 KB)

Published:

02 June 2020
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 255 KB)

Published:

02 June 2020
Final stakeholder list (PDF 166 KB)

Published:

30 March 2021

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope pre referral (PDF 217 KB)

Published:

26 November 2019
Draft matrix pre referral (PDF 183 KB)

Published:

26 November 2019